Position in TXG
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$3,934,795
+$661,257 QoQ
Shares Held
102,629
-33.4% QoQ
Ownership
0.079%
of shares outstanding
% of Portfolio
2.43%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TXG Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026Exome Asset Management LLC holds $13,379,559 across 6 Medical Devices names. TXG ranks #1 (29.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TXG |
10x Genomics, Inc.
This page
|
102,629 | $3,934,795 | |
| 2 | GKOS |
GLAUKOS Corp
|
19,862 | $2,775,913 | |
| 3 | BSX |
Boston Scientific Corp
|
48,347 | $2,063,449 | |
| 4 | PEN |
Penumbra Inc
|
6,300 | $1,989,225 | |
| 5 | CLPT |
ClearPoint Neuro, Inc.
|
83,636 | $1,492,066 | |
| 6 | ESTA |
Establishment Labs Holdings Inc.
|
13,100 | $1,124,111 |
All Filings in TXG
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,934,795 | 102,629 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $3,273,538 | 154,194 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $2,669,261 | 163,658 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $1,913,162 | 163,658 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $1,895,159 | 163,658 | Shares | Sole | 2025-08-15 | |
| No filing history on record for this holder in this stock. | ||||||